|
|
Genesis’s TCM Flu Treatment Approved by SFDA
publication date: Jul 15, 2008
Genesis Pharmaceuticals Enterprises was granted SFDA approval for Radix Isatidis Dispersible Tablets. Radix Isatidis is a very popular traditional Chinese medicine used to treat the flu, though it was previously available only as a powder, which is dissolved in hot water. The Genesis formulation is the only dispersible tablet available. As a whole, Radix Isatidis is a $1.4 billion market annually. Genesis forecasts that it will manufacture and sell somewhere between $4 million and $10 million of its product in the next fiscal year (which ends June 30, 2009). More details...
Stock Symbol: (OTCBB: GTEC)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|